FUSI FABIO
Office hours
-
Monday from 11:00 to 13:00Place: Studio del docente - Polo Scientifico Universitario di San MiniatoNote: Previo appuntamento
The Professor receives by appointment by email.
Contacts
0577235377 [int.5377] (Lab Patch 1),0577235203 [int.5203] (Ufficio),0577232375 [int.2375] (Lab Patch 2)
Curriculum Vitae
Teaching activities
Completion accademic year: 2025/2026
Completion accademic year: 2024/2025
Completion accademic year: 2023/2024
Research
Ultime pubblicazioni:
- Carullo, G., Falbo, F., Tudino, V., Song, J., Fava, M., Fontana, A., et al. (2026). Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo. JOURNAL OF MEDICINAL CHEMISTRY, 69(2), 1049-1074 [10.1021/acs.jmedchem.5c02237]. - view more
- Gentile, M., Panti, A., Paccagnini, E., Lupetti, P., Bova, S., Fusi, F. (2025). Ba2+-Induced Vasoconstriction as a Model to Investigate the Dynamin Dependence of Biological Processes Regulating Vascular Tone. PHARMACOLOGY RESEARCH & PERSPECTIVES, 13(6) [10.1002/prp2.70184]. - view more
- Fusi, F., Saponara, S., Carullo, G., Panti, A., Bichicchi, A., Pifferi, A., et al. (2025). The insulin-releasing agent quercetin-3-oleate stimulates CaV1.2 channels similarly to quercetin, though with a reduced vasorelaxant activity. EUROPEAN JOURNAL OF PHARMACOLOGY, 1003 [10.1016/j.ejphar.2025.177902]. - view more
- Ibba, R., Sestito, S., Ambrosio, F.A., Marchese, E., Costa, G., Fiorentino, F.P., et al. (2024). Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 276 [10.1016/j.ejmech.2024.116647]. - view more
- Salaroglio, I.C., Stefanova, D., Teixeira, R.G., Oliveira, N.F.B., Ahmed, A., Fusi, F., et al. (2024). A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound. PHARMACOLOGICAL RESEARCH, 208 [10.1016/j.phrs.2024.107353]. - view more